In a recent release, BioMed Realty and the University of California San Diego (UC San Diego) celebrated the grand opening of the Center for Novel Therapeutics (CNT) on the UC San Diego Science Research Park campus. The new 137,500 square foot research hub leverages the strength of UC San Diego Moores Cancer Center with private sector companies looking to translate research into helping cancer patients throughout the world. The development represents a $92 million investment by BioMed Realty, a global leader in life science real estate.
As a result of UC San Diego’s partnership with BioMed Realty, CNT will stand as San Diego’s newest dedicated oncology research center, with best-in-class facilities to advance life-changing treatments for cancer patients. Additionally, CNT includes the first academic-industry drug discovery incubator site in San Diego. CNT will facilitate UC San Diego’s “bench to bedside” approach, the transition of research from the laboratory space into the clinic and to patients by promoting new therapies.
The CNT building leverages BioMed Realty’s focus on collaboration and sustainability efforts, which resulted in the project being awarded LEED Gold Certification. BioMed Realty designed the project with UC San Diego to incorporate high efficiency water-cooled central cooling, LED energy efficient light fixtures throughout, and photo-voltaic solar panels in the roof of the atrium and other parts of the building.